Literature DB >> 7164088

Antitumor effect of 1 alpha-hydroxyvitamin D3.

T Sato, K Takusagawa, N Asoo, K Konno.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7164088     DOI： 10.1620/tjem.138.445

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN： 0040-8727            Impact factor:   1.848


× No keyword cloud information.
  5 in total

1.  1 alpha,25-Dihydroxyvitamin D3 inhibits the invasive potential of human breast cancer cells in vitro.

Authors:  C M Hansen; T L Frandsen; N Brünner; L Binderup
Journal:  Clin Exp Metastasis       Date:  1994-05       Impact factor: 5.150

2.  1 alpha-hydroxyvitamin D3, hypercalcemia, and growth suppression of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.

Authors:  Y Iino; M Yoshida; N Sugamata; M Maemura; S Ohwada; T Yokoe; T Ishikita; R Horiuchi; Y Morishita
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

3.  Alfacalcidol as a modulator of growth of low grade non-Hodgkin's lymphomas.

Authors:  D Cunningham; N L Gilchrist; R A Cowan; G J Forrest; C S McArdle; M Soukop
Journal:  Br Med J (Clin Res Ed)       Date:  1985-10-26

4.  Effect of 1 alpha-hydroxyvitamin D3 on metastasis of rat ascites hepatoma K-231.

Authors:  T Sato; K Takusagawa; N Asoo; K Konno
Journal:  Br J Cancer       Date:  1984-07       Impact factor: 7.640

5.  Calcitriol and cancer therapy: A missed opportunity.

Authors:  Donald L Trump
Journal:  Bone Rep       Date:  2018-06-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.